Esobiz HP Kit is a combination pharmaceutical formulation containing Amoxycillin 750 mg, Clarithromycin 500 mg, and Esomeprazole 40 mg, indicated primarily for the eradication of Helicobacter pylori infection associated with peptic ulcer disease and gastritis. Amoxycillin, a broad-spectrum beta-lactam antibiotic, acts by inhibiting bacterial cell wall synthesis, thereby exerting bactericidal effects. Clarithromycin, a macrolide antibiotic, inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, enhancing the antimicrobial spectrum against H. pylori. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, creating an optimal gastric pH environment that enhances antibiotic efficacy and promotes mucosal healing. The combined use of these agents in Esobiz HP Kit improves eradication rates of H. pylori, reduces the risk of ulcer recurrence, and alleviates associated gastrointestinal symptoms. This regimen is typically administered orally for a duration prescribed by a healthcare professional, often ranging from 7 to 14 days. Caution is advised in patients with known hypersensitivity to any component, and potential drug interactions should be reviewed prior to initiation. Adherence to prescribed dosing and completion of the full course are essential to prevent antibiotic resistance and ensure therapeutic success.